SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1v6u'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HK3_A_T44A3004_1 (SERUM ALBUMIN)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	4 / 7	GLU A 236 LEU A 237 VAL A 250 LEU A 222	XYP A 452 (-2.7A) None None None	1.01A	1hk3A-1v6uA: undetectable	1hk3A-1v6uA: 19.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1N4F_A_ASRA140_0 (LYSOZYME C)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	ASN A 298 ALA A 248 ASN A 252	None	0.79A	1n4fA-1v6uA: undetectable	1n4fA-1v6uA: 14.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1S19_A_MC9A500_0 (VITAMIN D3 RECEPTOR)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	5 / 12	LEU A 222 LEU A 228 VAL A 230 ILE A 199 TYR A 186	None	1.16A	1s19A-1v6uA: undetectable	1s19A-1v6uA: 20.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2H42_C_VIAC903_2 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	ASN A 170 ILE A 199 MET A 188	None	0.82A	2h42C-1v6uA: undetectable	2h42C-1v6uA: 20.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FHJ_A_TRPA1001_0 (TRYPTOPHANYL-TRNA SYNTHETASE)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	5 / 10	GLN A 89 MET A 105 ILE A 109 VAL A 125 VAL A 126	None	1.18A	3fhjA-1v6uA: undetectable	3fhjA-1v6uA: 21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FHJ_B_TRPB1001_0 (TRYPTOPHANYL-TRNA SYNTHETASE)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	5 / 10	GLN A 89 MET A 105 ILE A 109 VAL A 125 VAL A 126	None	1.20A	3fhjB-1v6uA: undetectable	3fhjB-1v6uA: 21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FHJ_C_TRPC1001_0 (TRYPTOPHANYL-TRNA SYNTHETASE)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	5 / 10	GLN A 89 MET A 105 ILE A 109 VAL A 125 VAL A 126	None	1.18A	3fhjC-1v6uA: undetectable	3fhjC-1v6uA: 21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FHJ_E_TRPE1001_0 (TRYPTOPHANYL-TRNA SYNTHETASE)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	5 / 10	GLN A 89 MET A 105 ILE A 109 VAL A 125 VAL A 126	None	1.19A	3fhjE-1v6uA: undetectable	3fhjE-1v6uA: 21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RET_A_SALA201_1 (SALICYLATE BIOSYNTHESIS PROTEIN PCHB)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	5 / 10	VAL A 189 ALA A 226 VAL A 232 TYR A 169 ILE A 199	None	1.50A	3retA-1v6uA: undetectable 3retB-1v6uA: undetectable	3retA-1v6uA: 12.85 3retB-1v6uA: 12.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W9T_A_W9TA1001_1 (HEMOLYTIC LECTIN CEL-III)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	4 / 5	ASP A 408 VAL A 410 GLY A 411 TYR A 423	XYP A 471 (-2.8A) XYP A 471 (-4.5A) XYP A 471 (-3.5A) XYP A 471 (-3.5A)	0.50A	3w9tA-1v6uA: 18.4	3w9tA-1v6uA: 20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W9T_B_W9TB503_1 (HEMOLYTIC LECTIN CEL-III)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	4 / 5	ASP A 408 VAL A 410 GLY A 411 TYR A 423	XYP A 471 (-2.8A) XYP A 471 (-4.5A) XYP A 471 (-3.5A) XYP A 471 (-3.5A)	0.49A	3w9tB-1v6uA: 8.7	3w9tB-1v6uA: 20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W9T_C_W9TC1001_1 (HEMOLYTIC LECTIN CEL-III)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	4 / 5	ASP A 408 VAL A 410 GLY A 411 TYR A 423	XYP A 471 (-2.8A) XYP A 471 (-4.5A) XYP A 471 (-3.5A) XYP A 471 (-3.5A)	0.50A	3w9tC-1v6uA: 15.0	3w9tC-1v6uA: 20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W9T_C_W9TC1005_1 (HEMOLYTIC LECTIN CEL-III)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	ASP A 408 GLY A 411 TYR A 423	XYP A 471 (-2.8A) XYP A 471 (-3.5A) XYP A 471 (-3.5A)	0.58A	3w9tC-1v6uA: 7.8	3w9tC-1v6uA: 20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W9T_D_W9TD502_1 (HEMOLYTIC LECTIN CEL-III)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	4 / 5	ASP A 408 VAL A 410 GLY A 411 TYR A 423	XYP A 471 (-2.8A) XYP A 471 (-4.5A) XYP A 471 (-3.5A) XYP A 471 (-3.5A)	0.49A	3w9tD-1v6uA: 18.8	3w9tD-1v6uA: 20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W9T_E_W9TE504_1 (HEMOLYTIC LECTIN CEL-III)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	4 / 5	ASP A 408 VAL A 410 GLY A 411 TYR A 423	XYP A 471 (-2.8A) XYP A 471 (-4.5A) XYP A 471 (-3.5A) XYP A 471 (-3.5A)	0.50A	3w9tE-1v6uA: 8.9	3w9tE-1v6uA: 20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W9T_F_W9TF504_1 (HEMOLYTIC LECTIN CEL-III)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	4 / 5	ASP A 408 VAL A 410 GLY A 411 TYR A 423	XYP A 471 (-2.8A) XYP A 471 (-4.5A) XYP A 471 (-3.5A) XYP A 471 (-3.5A)	0.48A	3w9tF-1v6uA: 18.8	3w9tF-1v6uA: 20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W9T_G_W9TG503_1 (HEMOLYTIC LECTIN CEL-III)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	ASP A 408 GLY A 411 TYR A 423	XYP A 471 (-2.8A) XYP A 471 (-3.5A) XYP A 471 (-3.5A)	0.58A	3w9tG-1v6uA: 9.0	3w9tG-1v6uA: 20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3W9T_G_W9TG504_1 (HEMOLYTIC LECTIN CEL-III)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	4 / 5	ASP A 408 VAL A 410 GLY A 411 TYR A 423	XYP A 471 (-2.8A) XYP A 471 (-4.5A) XYP A 471 (-3.5A) XYP A 471 (-3.5A)	0.49A	3w9tG-1v6uA: 18.8	3w9tG-1v6uA: 20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZQ8_D_DVAD8_0 (VAL-GRAMICIDIN A)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	TRP A 274 VAL A 265 TRP A 266	XYP A 452 (-4.3A) None XYP A 451 ( 4.1A)	0.93A	3zq8C-1v6uA: undetectable 3zq8D-1v6uA: undetectable	3zq8C-1v6uA: 5.11 3zq8D-1v6uA: 5.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C5N_C_PXLC300_1 (PHOSPHOMETHYLPYRIMID INE KINASE)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	4 / 8	ASP A 65 GLY A 64 VAL A 78 HIS A 115	None	0.80A	4c5nC-1v6uA: 3.2	4c5nC-1v6uA: 20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PEV_C_ADNC501_1 (MEMBRANE LIPOPROTEIN FAMILY PROTEIN)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	5 / 12	ASN A 39 LEU A 282 PHE A 283 PHE A 16 GLY A 17	None	1.31A	4pevC-1v6uA: undetectable	4pevC-1v6uA: 24.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	5 / 10	ALA A 295 THR A 294 GLY A 303 GLY A 302 ALA A 299	None	1.07A	4qw3K-1v6uA: undetectable 4qw3L-1v6uA: undetectable	4qw3K-1v6uA: 20.42 4qw3L-1v6uA: 19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW3_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	5 / 10	ALA A 295 THR A 294 GLY A 303 GLY A 302 ALA A 299	None	1.07A	4qw3Y-1v6uA: undetectable 4qw3Z-1v6uA: undetectable	4qw3Y-1v6uA: 20.42 4qw3Z-1v6uA: 19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XP4_A_COCA706_1 (DOPAMINE TRANSPORTER)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	5 / 11	PHE A 204 ASP A 171 VAL A 189 TYR A 169 PHE A 225	None	1.16A	4xp4A-1v6uA: undetectable	4xp4A-1v6uA: 22.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XPB_A_COCA702_1 (TRANSPORTER)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	5 / 10	PHE A 204 ASP A 171 VAL A 189 TYR A 169 PHE A 225	None	1.20A	4xpbA-1v6uA: 0.0	4xpbA-1v6uA: 22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z91_J_4LEJ401_1 (GAMMA-AMINOBUTYRIC-A CID RECEPTOR SUBUNIT BETA-1)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	6 / 9	LEU A 300 ALA A 299 ALA A 248 ALA A 292 LEU A 282 LEU A 5	None	1.26A	4z91F-1v6uA: 0.0 4z91G-1v6uA: 0.0 4z91H-1v6uA: 0.0 4z91I-1v6uA: 0.0 4z91J-1v6uA: undetectable	4z91F-1v6uA: 20.77 4z91G-1v6uA: 20.77 4z91H-1v6uA: 20.77 4z91I-1v6uA: 20.77 4z91J-1v6uA: 20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B2Q_A_ACTA1728_0 (CRISPR-ASSOCIATED ENDONUCLEASE CAS9)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	ASN A 173 SER A 212 ARG A 275	XYP A 457 (-3.4A) XYP A 457 (-3.1A) XYP A 457 ( 3.2A)	0.73A	5b2qA-1v6uA: 1.2	5b2qA-1v6uA: 12.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	5 / 9	ALA A 295 THR A 294 GLY A 303 GLY A 302 ALA A 299	None	1.06A	5d0xK-1v6uA: undetectable 5d0xL-1v6uA: undetectable	5d0xK-1v6uA: 20.51 5d0xL-1v6uA: 19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	5 / 9	ALA A 295 THR A 294 GLY A 303 GLY A 302 ALA A 299	None	1.07A	5d0xY-1v6uA: undetectable 5d0xZ-1v6uA: undetectable	5d0xY-1v6uA: 20.51 5d0xZ-1v6uA: 19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5G5G_B_ACTB1321_0 (PUTATIVE XANTHINE DEHYDROGENASE YAGR MOLYBDENUM-BINDING SU SUBUNIT)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	THR A 353 ASP A 354 ALA A 355	None	0.05A	5g5gB-1v6uA: undetectable	5g5gB-1v6uA: 22.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JHD_E_EDTE301_0 (BETA-2-MICROGLOBULIN TCRBETA CHAIN)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	4 / 8	TYR A 361 SER A 330 THR A 332 THR A 335	None	1.04A	5jhdE-1v6uA: undetectable 5jhdG-1v6uA: undetectable	5jhdE-1v6uA: 22.43 5jhdG-1v6uA: 15.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5N0O_B_SAMB501_0 (PEPTIDE N-METHYLTRANSFERASE)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	5 / 12	ILE A 20 SER A 22 ALA A 21 ALA A 19 VAL A 268	None	1.08A	5n0oB-1v6uA: undetectable	5n0oB-1v6uA: 25.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QGM_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.64A	5qgmA-1v6uA: undetectable	5qgmA-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QGN_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.64A	5qgnA-1v6uA: undetectable	5qgnA-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QGU_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.70A	5qguA-1v6uA: undetectable	5qguA-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QGV_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.63A	5qgvA-1v6uA: undetectable	5qgvA-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QGW_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.64A	5qgwA-1v6uA: undetectable	5qgwA-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QGX_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.63A	5qgxA-1v6uA: undetectable	5qgxA-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QGY_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.63A	5qgyA-1v6uA: undetectable	5qgyA-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QGZ_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.63A	5qgzA-1v6uA: undetectable	5qgzA-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QH0_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.66A	5qh0A-1v6uA: undetectable	5qh0A-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QH1_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.62A	5qh1A-1v6uA: undetectable	5qh1A-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QH2_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.63A	5qh2A-1v6uA: undetectable	5qh2A-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QH3_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.63A	5qh3A-1v6uA: undetectable	5qh3A-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QH4_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.66A	5qh4A-1v6uA: undetectable	5qh4A-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QH5_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.60A	5qh5A-1v6uA: undetectable	5qh5A-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QH6_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.62A	5qh6A-1v6uA: undetectable	5qh6A-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QH7_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.64A	5qh7A-1v6uA: undetectable	5qh7A-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QH9_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.64A	5qh9A-1v6uA: undetectable	5qh9A-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QHA_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.67A	5qhaA-1v6uA: undetectable	5qhaA-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QHC_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.68A	5qhcA-1v6uA: undetectable	5qhcA-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QHE_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.67A	5qheA-1v6uA: undetectable	5qheA-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QHF_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.63A	5qhfA-1v6uA: undetectable	5qhfA-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QHG_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.63A	5qhgA-1v6uA: undetectable	5qhgA-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5QHH_A_ACTA301_0 (PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	3 / 3	VAL A 326 VAL A 337 GLN A 378	None	0.66A	5qhhA-1v6uA: undetectable	5qhhA-1v6uA: 18.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CB4_A_BEZA501_0 (CANAVALIN)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	4 / 8	LEU A 358 VAL A 337 LEU A 324 ILE A 420	None	0.95A	6cb4A-1v6uA: undetectable	6cb4A-1v6uA: 21.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GTQ_A_ACTA204_0 (N-ACETYLTRANSFERASE)	1v6u	ENDO-1,4-BETA-D-XYLA NASE (Streptomyces olivaceoviridis)	4 / 5	LEU A 96 THR A 100 THR A 146 GLY A 98	None	1.25A	6gtqA-1v6uA: undetectable	6gtqA-1v6uA: 17.17

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1HK3_A_T44A3004_1","SERUM ALBUMIN","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",4,"GLU A 236;LEU A 237;VAL A 250;LEU A 222","XYP A 452 (-2.7A);None;None;None","1.01A","1hk3A-1v6uA:undetectable","1hk3A-1v6uA:19.03"],["1N4F_A_ASRA140_0","LYSOZYME C","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"ASN A 298;ALA A 248;ASN A 252","None","0.79A","1n4fA-1v6uA:undetectable","1n4fA-1v6uA:14.55"],["1S19_A_MC9A500_0","VITAMIN D3 RECEPTOR","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",5,"LEU A 222;LEU A 228;VAL A 230;ILE A 199;TYR A 186","None","1.16A","1s19A-1v6uA:undetectable","1s19A-1v6uA:20.19"],["2H42_C_VIAC903_2","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"ASN A 170;ILE A 199;MET A 188","None","0.82A","2h42C-1v6uA:undetectable","2h42C-1v6uA:20.35"],["3FHJ_A_TRPA1001_0","TRYPTOPHANYL-TRNA SYNTHETASE","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",5,"GLN A  89;MET A 105;ILE A 109;VAL A 125;VAL A 126","None","1.18A","3fhjA-1v6uA:undetectable","3fhjA-1v6uA:21.10"],["3FHJ_B_TRPB1001_0","TRYPTOPHANYL-TRNA SYNTHETASE","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",5,"GLN A  89;MET A 105;ILE A 109;VAL A 125;VAL A 126","None","1.20A","3fhjB-1v6uA:undetectable","3fhjB-1v6uA:21.10"],["3FHJ_C_TRPC1001_0","TRYPTOPHANYL-TRNA SYNTHETASE","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",5,"GLN A  89;MET A 105;ILE A 109;VAL A 125;VAL A 126","None","1.18A","3fhjC-1v6uA:undetectable","3fhjC-1v6uA:21.10"],["3FHJ_E_TRPE1001_0","TRYPTOPHANYL-TRNA SYNTHETASE","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",5,"GLN A  89;MET A 105;ILE A 109;VAL A 125;VAL A 126","None","1.19A","3fhjE-1v6uA:undetectable","3fhjE-1v6uA:21.10"],["3RET_A_SALA201_1","SALICYLATE BIOSYNTHESIS PROTEIN PCHB;SALICYLATE BIOSYNTHESIS PROTEIN PCHB","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",5,"VAL A 189;ALA A 226;VAL A 232;TYR A 169;ILE A 199","None","1.50A","3retA-1v6uA:undetectable;3retB-1v6uA:undetectable","3retA-1v6uA:12.85;3retB-1v6uA:12.85"],["3W9T_A_W9TA1001_1","HEMOLYTIC LECTIN CEL-III","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",4,"ASP A 408;VAL A 410;GLY A 411;TYR A 423","XYP A 471 (-2.8A);XYP A 471 (-4.5A);XYP A 471 (-3.5A);XYP A 471 (-3.5A)","0.50A","3w9tA-1v6uA:18.4","3w9tA-1v6uA:20.97"],["3W9T_B_W9TB503_1","HEMOLYTIC LECTIN CEL-III","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",4,"ASP A 408;VAL A 410;GLY A 411;TYR A 423","XYP A 471 (-2.8A);XYP A 471 (-4.5A);XYP A 471 (-3.5A);XYP A 471 (-3.5A)","0.49A","3w9tB-1v6uA:8.7","3w9tB-1v6uA:20.97"],["3W9T_C_W9TC1001_1","HEMOLYTIC LECTIN CEL-III","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",4,"ASP A 408;VAL A 410;GLY A 411;TYR A 423","XYP A 471 (-2.8A);XYP A 471 (-4.5A);XYP A 471 (-3.5A);XYP A 471 (-3.5A)","0.50A","3w9tC-1v6uA:15.0","3w9tC-1v6uA:20.97"],["3W9T_C_W9TC1005_1","HEMOLYTIC LECTIN CEL-III","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"ASP A 408;GLY A 411;TYR A 423","XYP A 471 (-2.8A);XYP A 471 (-3.5A);XYP A 471 (-3.5A)","0.58A","3w9tC-1v6uA:7.8","3w9tC-1v6uA:20.97"],["3W9T_D_W9TD502_1","HEMOLYTIC LECTIN CEL-III","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",4,"ASP A 408;VAL A 410;GLY A 411;TYR A 423","XYP A 471 (-2.8A);XYP A 471 (-4.5A);XYP A 471 (-3.5A);XYP A 471 (-3.5A)","0.49A","3w9tD-1v6uA:18.8","3w9tD-1v6uA:20.97"],["3W9T_E_W9TE504_1","HEMOLYTIC LECTIN CEL-III","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",4,"ASP A 408;VAL A 410;GLY A 411;TYR A 423","XYP A 471 (-2.8A);XYP A 471 (-4.5A);XYP A 471 (-3.5A);XYP A 471 (-3.5A)","0.50A","3w9tE-1v6uA:8.9","3w9tE-1v6uA:20.97"],["3W9T_F_W9TF504_1","HEMOLYTIC LECTIN CEL-III","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",4,"ASP A 408;VAL A 410;GLY A 411;TYR A 423","XYP A 471 (-2.8A);XYP A 471 (-4.5A);XYP A 471 (-3.5A);XYP A 471 (-3.5A)","0.48A","3w9tF-1v6uA:18.8","3w9tF-1v6uA:20.97"],["3W9T_G_W9TG503_1","HEMOLYTIC LECTIN CEL-III","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"ASP A 408;GLY A 411;TYR A 423","XYP A 471 (-2.8A);XYP A 471 (-3.5A);XYP A 471 (-3.5A)","0.58A","3w9tG-1v6uA:9.0","3w9tG-1v6uA:20.97"],["3W9T_G_W9TG504_1","HEMOLYTIC LECTIN CEL-III","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",4,"ASP A 408;VAL A 410;GLY A 411;TYR A 423","XYP A 471 (-2.8A);XYP A 471 (-4.5A);XYP A 471 (-3.5A);XYP A 471 (-3.5A)","0.49A","3w9tG-1v6uA:18.8","3w9tG-1v6uA:20.97"],["3ZQ8_D_DVAD8_0","VAL-GRAMICIDIN A","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"TRP A 274;VAL A 265;TRP A 266","XYP A 452 (-4.3A);None;XYP A 451 ( 4.1A)","0.93A","3zq8C-1v6uA:undetectable;3zq8D-1v6uA:undetectable","3zq8C-1v6uA:5.11;3zq8D-1v6uA:5.11"],["4C5N_C_PXLC300_1","PHOSPHOMETHYLPYRIMIDINE KINASE","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",4,"ASP A  65;GLY A  64;VAL A  78;HIS A 115","None","0.80A","4c5nC-1v6uA:3.2","4c5nC-1v6uA:20.09"],["4PEV_C_ADNC501_1","MEMBRANE LIPOPROTEIN FAMILY PROTEIN","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",5,"ASN A  39;LEU A 282;PHE A 283;PHE A  16;GLY A  17","None","1.31A","4pevC-1v6uA:undetectable","4pevC-1v6uA:24.58"],["4QW3_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",5,"ALA A 295;THR A 294;GLY A 303;GLY A 302;ALA A 299","None","1.07A","4qw3K-1v6uA:undetectable;4qw3L-1v6uA:undetectable","4qw3K-1v6uA:20.42;4qw3L-1v6uA:19.41"],["4QW3_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",5,"ALA A 295;THR A 294;GLY A 303;GLY A 302;ALA A 299","None","1.07A","4qw3Y-1v6uA:undetectable;4qw3Z-1v6uA:undetectable","4qw3Y-1v6uA:20.42;4qw3Z-1v6uA:19.41"],["4XP4_A_COCA706_1","DOPAMINE TRANSPORTER","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",5,"PHE A 204;ASP A 171;VAL A 189;TYR A 169;PHE A 225","None","1.16A","4xp4A-1v6uA:undetectable","4xp4A-1v6uA:22.60"],["4XPB_A_COCA702_1","TRANSPORTER","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",5,"PHE A 204;ASP A 171;VAL A 189;TYR A 169;PHE A 225","None","1.20A","4xpbA-1v6uA:0.0","4xpbA-1v6uA:22.32"],["4Z91_J_4LEJ401_1","GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1;GAMMA-AMINOBUTYRIC-ACID RECEPTOR SUBUNIT BETA-1","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",6,"LEU A 300;ALA A 299;ALA A 248;ALA A 292;LEU A 282;LEU A   5","None","1.26A","4z91F-1v6uA:0.0;4z91G-1v6uA:0.0;4z91H-1v6uA:0.0;4z91I-1v6uA:0.0;4z91J-1v6uA:undetectable","4z91F-1v6uA:20.77;4z91G-1v6uA:20.77;4z91H-1v6uA:20.77;4z91I-1v6uA:20.77;4z91J-1v6uA:20.77"],["5B2Q_A_ACTA1728_0","CRISPR-ASSOCIATED ENDONUCLEASE CAS9","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"ASN A 173;SER A 212;ARG A 275","XYP A 457 (-3.4A);XYP A 457 (-3.1A);XYP A 457 ( 3.2A)","0.73A","5b2qA-1v6uA:1.2","5b2qA-1v6uA:12.46"],["5D0X_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",5,"ALA A 295;THR A 294;GLY A 303;GLY A 302;ALA A 299","None","1.06A","5d0xK-1v6uA:undetectable;5d0xL-1v6uA:undetectable","5d0xK-1v6uA:20.51;5d0xL-1v6uA:19.41"],["5D0X_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",5,"ALA A 295;THR A 294;GLY A 303;GLY A 302;ALA A 299","None","1.07A","5d0xY-1v6uA:undetectable;5d0xZ-1v6uA:undetectable","5d0xY-1v6uA:20.51;5d0xZ-1v6uA:19.41"],["5G5G_B_ACTB1321_0","PUTATIVE XANTHINE DEHYDROGENASE YAGR MOLYBDENUM-BINDING SU SUBUNIT","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"THR A 353;ASP A 354;ALA A 355","None","0.05A","5g5gB-1v6uA:undetectable","5g5gB-1v6uA:22.92"],["5JHD_E_EDTE301_0","BETA-2-MICROGLOBULIN;TCRBETA CHAIN","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",4,"TYR A 361;SER A 330;THR A 332;THR A 335","None","1.04A","5jhdE-1v6uA:undetectable;5jhdG-1v6uA:undetectable","5jhdE-1v6uA:22.43;5jhdG-1v6uA:15.66"],["5N0O_B_SAMB501_0","PEPTIDE N-METHYLTRANSFERASE","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",5,"ILE A  20;SER A  22;ALA A  21;ALA A  19;VAL A 268","None","1.08A","5n0oB-1v6uA:undetectable","5n0oB-1v6uA:25.16"],["5QGM_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.64A","5qgmA-1v6uA:undetectable","5qgmA-1v6uA:18.89"],["5QGN_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.64A","5qgnA-1v6uA:undetectable","5qgnA-1v6uA:18.89"],["5QGU_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.70A","5qguA-1v6uA:undetectable","5qguA-1v6uA:18.89"],["5QGV_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.63A","5qgvA-1v6uA:undetectable","5qgvA-1v6uA:18.89"],["5QGW_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.64A","5qgwA-1v6uA:undetectable","5qgwA-1v6uA:18.89"],["5QGX_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.63A","5qgxA-1v6uA:undetectable","5qgxA-1v6uA:18.89"],["5QGY_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.63A","5qgyA-1v6uA:undetectable","5qgyA-1v6uA:18.89"],["5QGZ_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.63A","5qgzA-1v6uA:undetectable","5qgzA-1v6uA:18.89"],["5QH0_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.66A","5qh0A-1v6uA:undetectable","5qh0A-1v6uA:18.89"],["5QH1_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.62A","5qh1A-1v6uA:undetectable","5qh1A-1v6uA:18.89"],["5QH2_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.63A","5qh2A-1v6uA:undetectable","5qh2A-1v6uA:18.89"],["5QH3_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.63A","5qh3A-1v6uA:undetectable","5qh3A-1v6uA:18.89"],["5QH4_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.66A","5qh4A-1v6uA:undetectable","5qh4A-1v6uA:18.89"],["5QH5_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.60A","5qh5A-1v6uA:undetectable","5qh5A-1v6uA:18.89"],["5QH6_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.62A","5qh6A-1v6uA:undetectable","5qh6A-1v6uA:18.89"],["5QH7_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.64A","5qh7A-1v6uA:undetectable","5qh7A-1v6uA:18.89"],["5QH9_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.64A","5qh9A-1v6uA:undetectable","5qh9A-1v6uA:18.89"],["5QHA_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.67A","5qhaA-1v6uA:undetectable","5qhaA-1v6uA:18.89"],["5QHC_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.68A","5qhcA-1v6uA:undetectable","5qhcA-1v6uA:18.89"],["5QHE_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.67A","5qheA-1v6uA:undetectable","5qheA-1v6uA:18.89"],["5QHF_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.63A","5qhfA-1v6uA:undetectable","5qhfA-1v6uA:18.89"],["5QHG_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.63A","5qhgA-1v6uA:undetectable","5qhgA-1v6uA:18.89"],["5QHH_A_ACTA301_0","PEROXISOMAL COENZYME A DIPHOSPHATASE NUDT7","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",3,"VAL A 326;VAL A 337;GLN A 378","None","0.66A","5qhhA-1v6uA:undetectable","5qhhA-1v6uA:18.89"],["6CB4_A_BEZA501_0","CANAVALIN","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",4,"LEU A 358;VAL A 337;LEU A 324;ILE A 420","None","0.95A","6cb4A-1v6uA:undetectable","6cb4A-1v6uA:21.86"],["6GTQ_A_ACTA204_0","N-ACETYLTRANSFERASE","1v6u","ENDO-1,4-BETA-D-XYLANASE","Streptomyces olivaceoviridis",4,"LEU A  96;THR A 100;THR A 146;GLY A  98","None","1.25A","6gtqA-1v6uA:undetectable","6gtqA-1v6uA:17.17"]]